In a recent article published on Substack, Martin Shkreli, the disgraced biotech entrepreneur, claims that Paul Le Roux, former programmer and ex-criminal cartel leader, is the real Satoshi Nakamoto.
That “‘pharma broappears to have decrypted the very first transfer sent to late Bitcoin pioneer Hal Finney.
Le Roux was arrested in 2012 after being lured into a trap by the Drug Enforcement Administration. During an undercover operation organized by the DEA, a paid informant secretly recorded gangster.
The drug lord and arms dealer was sentenced to 25 years in prison in June 2020. Le Roux could have spent the rest of his life behind bars, but his sentence was reduced due to the extensive assistance he brought to the DEA.
The coder turned kingpin has been a top contender for Satoshi Nakamoto for some time. A Wired article published in 2019 suggests that there is evidence that bitcoin was created by the criminal mastermind.
The Bitcoin community poured cold water on Shkreli’s latest revelation. Prominent Bitcoin Core developer Peter Wuille claims that his blog post only proves that someone with access to Finney’s private key signed the alleged message.
only proves that someone with access to Hal Finney’s private key (not Satoshi’s) signed the alleged message. They also spelled his name wrong.
— Pieter Wuille (@pwoille) 13 December 2022
Greg Maxwell, another well-known developer, also disputed Shkreli’s claims, claiming that the type of signature used by the alleged Satoshi only existed after Finney’s was shut down. Therefore, it only proves that someone controls the deceased software developer’s private key.
If Shkreli is right, it means that Le Roux likely created Bitcoin as a money laundering tool to support his criminal empire, validating the warnings of many cryptocurrency opponents.
Who is Martin Shkreli?
Martin Shkreli is an American entrepreneur and former CEO of Turing Pharmaceuticals. Born in September 1983 in Brooklyn, New York, he grew up in modest circumstances and began his professional career at the age of 17 working for an online brokerage firm. After leaving the company in 2009, Shkreli founded several biotech and pharmaceutical services companies.
In 2015, Shkreli became the controversial CEO of Turing Pharmaceuticals, shocking the world by raising the price of an HIV/AIDS drug by about 5,500%. This decision caused international controversy and criticism throughout the United States and the rest of the world.
In 2016, Shkreli was convicted of stock fraud and sentenced to 7 years in prison. He is currently serving his sentence in a federal prison in New Jersey. He became known for his arrogant and defiant behavior on social media, earning him the nickname “Pharma Bro” by the press.
Despite his controversy, Shkreli remains an important figure in the American pharmaceutical industry and is considered a pioneer in biomedical technologies.